Experimental Bausch + Lomb Glaucoma Treatment Proves Effective

Bausch + Lomb’s experimental glaucoma medication, BOL 303259-X, has shown a greater reduction of intraocular pressure than the current standard glaucoma treatment, latanoprost, according to a Medscape report.

Advertisement

Robert Weinreb, MD, of the University of California San Diego, presented the results of the study at the 23rd Annual American Glaucoma Society Meeting in March.

More Articles on Ophthalmology:
Dr. Christopher Calvin Brown Joins San Antonio Eye Center
Bausch + Lomb Files for Public Offering to Meet $700M Financial Obligation
Durrie Vision Helps Develop SBK LASIK

Advertisement

Next Up in Ophthalmology

  • Southlake, Texas-based Retina Consultants of America has acquired Montana Retina Consultants, according to a Feb. 5 news release.  Bozeman-based Montana…

  • Vision Innovation Partners acquired Ophthalmic Associates of Alexandria (Va.), according to a Feb. 2 press release. Founded in 2010, Ophthalmic…

Advertisement

Comments are closed.